(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

FORMULAÇÕES FARMACÊUTICAS COMPREENDENDO TENOFOVIR E EMTRICITABINA

ArquivadaInvention PatentPCT · US2016040158

Application data

Number

112017027843

Type

Invention Patent

Filing

06/29/2016

Publication

09/04/2018

PCT

US2016040158

Progress at the INPI

  1. Filing06/29/16
  2. Publication09/04/18
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 06/29/2016 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 10/01/2019. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

GILEAD SCIENCES, INC.

US

See this company's full portfolio

Inventors

J. K. (pessoa física)

US

S. M. (pessoa física)

US

Technical data

Priority claims

US

62/187,113 · 06/30/2015

US

62/298,373 · 02/22/2016

US

62/301,429 · 02/29/2016

US

62/317,286 · 04/01/2016

Abstract

A presente invenção se refere a uma forma de dosagem oral sólida a qual compreende alafenamida de tenofovir ou um sal farmaceuticamente aceitável da mesma, e emtricitabina ou um sal farmaceuticamente aceitável da mesma.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

10/01/2019

RPI 2543

Arquivamento - Art. 33 da LPI

#11.1

07/16/2019

RPI 2532

Notificação de entrada na fase nacional - PCT

#1.3

09/04/2018

RPI 2487

Alteração de dados cadastrais

#1.1

04/03/2018

RPI 2465

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.